Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2008
10/09/2008US20080249181 Compositions Having Antimycrobial Activity Including a Hydroxamate or a Hydroxamate and a Hydroxlyamine
10/09/2008US20080249164 Antimicrobial and Antinflammatory Composition
10/09/2008US20080249155 5-Hydroxyindole-3-Carboxylate Derivatives and Uses Thereof
10/09/2008US20080249151 Non-nucleoside reverse transcriptase inhibitors
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249146 Bicyclic antivirals for hepatitis C treatment; e.g. 1-cyclohexyl-2-phenyl-1H-thieno[3,2-d]imidazole-5-carboxylic acid
10/09/2008US20080249102 Hiv Protease Inhibitors
10/09/2008US20080249097 antiviral, anticancer chemotherapeutic agents; hydrophobic prodrugs of bases, nucleosides, and nucleotides; improved pharmacokinetic properties
10/09/2008US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders
10/09/2008US20080249087 Heterocylic antiviral compounds
10/09/2008US20080249085 for treating cell proliferative diseases; maytansinoid analogs; with lower systemic toxicity, improved pharmacokinetic profile, and better clinical activity; inhibiting fungal growth; compounds can target tubulin, Heat Shock Protein-90
10/09/2008US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
10/09/2008US20080249066 Antiviral compounds and compositions
10/09/2008US20080249061 Photostable Pharmaceutical Composition Containing Brivudine for the Treatment of Herpetic Keratitis
10/09/2008US20080249060 Nucleoside derivatives for treating hepatitis c virus infection
10/09/2008US20080249035 exhibits a characteristic X-ray diffraction pattern; dissolving clarithromycin in a ketone; precipitation is carried out by cooling
10/09/2008US20080249033 Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections
10/09/2008US20080249022 Systemic or local administration of a lipopolysaccharide binding polypeptide; neutralizes microbial toxins and allows natural host defence mechanisms to control spread of infection; otitis media; antibiotic resistance
10/09/2008US20080249015 Prophylaxis of influenza A infections; hypoglycemic agents; obesity; bulimia nervosa
10/09/2008US20080249002 Cyclosporin alkyne analogues and their pharmaceutical uses
10/09/2008US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
10/09/2008US20080248531 Preparation of fully human antibodies
10/09/2008US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity
10/09/2008US20080248087 Absorbent article
10/09/2008US20080248066 Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods using the modified microbes for the activation antigens
10/09/2008US20080248065 Gna1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis
10/09/2008US20080248063 Hetero-Oligomeric Hiv Envelope Proteins
10/09/2008US20080248062 virus-like particles (VLPs) of HPV, said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid. In preferred embodiments, the aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate.
10/09/2008US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation
10/09/2008US20080248046 Death domain containing receptor 5
10/09/2008US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
10/09/2008US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc
10/09/2008US20080248001 Methods and systems for treating cell proliferation disorders
10/09/2008US20080247992 N-Carboxyalkyl-1-cyclohexyl-2-substituted phenylbenzimidazole-5-carboxamides (2-[(1-cyclohexyl-2-{2-fluoro-4-[3-(aminocarbonyl)-6-(4-chlorophenyl)benzyloxy]-phenyl}-1H-benzimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid); Flavivirus family infections such as hepatitus C
10/09/2008US20080247960 Foaming Tropical Compositions
10/09/2008DE102007016367A1 Polymorph von Clarithromycin (Form V) Polymorph of clarithromycin (Form V)
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682639A1 Heterocyclic antiviral compounds
10/09/2008CA2682637A1 Non-nucleoside reverse transcriptase inhibitors
10/09/2008CA2682230A1 Nucleoside phosphoramidate prodrugs
10/09/2008CA2681828A1 Protein product for treatment of infectious diseases and related inflammatory processes
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978036A1 A mycobacterium tuberculosis fusion protein and uses thereof
10/08/2008EP1978021A1 Novel antibiotics
10/08/2008EP1977761A2 Pharmaceutical compositions containing protein nma0939
10/08/2008EP1977760A2 Method for Treating Cervical Cancer
10/08/2008EP1977759A1 Pharmaceutical composition comprising a cytokine
10/08/2008EP1977751A1 Use of crystalline (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole for manufacturing pharmaceutical compositions
10/08/2008EP1976853A1 Novel compounds and use thereof
10/08/2008EP1976837A1 Dicarbonylic compounds with antibacterial activity
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1976596A2 Anti-viral griffithsin compounds, compositions, and methods of use
10/08/2008EP1976561A2 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
10/08/2008EP1976556A2 Neisseria meningitidis vaccines and their use
10/08/2008EP1976543A1 Use of elderberry extract
10/08/2008EP1976542A1 Therapeutic use of an extract from the leaves of nerium oleander
10/08/2008EP1976539A2 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents
10/08/2008EP1976533A2 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
10/08/2008EP1976517A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors
10/08/2008EP1976516A2 Viral hepatitis treatment
10/08/2008EP1976497A2 Treatment of viral infections
10/08/2008EP1833978B1 Tripeptide and tetrapeptide thioethers
10/08/2008EP1833842B1 Tripeptide and tetrapeptide sulfones
10/08/2008EP1824863B1 Silicon compounds and their use
10/08/2008EP1809654B1 Heterocyclyl-substituted nonadepsipeptides
10/08/2008EP1703901B1 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
10/08/2008EP1678185B1 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis
10/08/2008EP1592452B1 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
10/08/2008EP1569931B1 Heterocyclic compounds as ccr5 antagonists
10/08/2008EP1370298B1 Elongated and multiple spacers in activatible prodrugs
10/08/2008EP1296633B1 Medicinal product package for eradication therapy
10/08/2008EP1274398B1 Methods for thepreparation of effervescent granules
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN201127787Y Externally used medicament tube for curing icterohepatitis
10/08/2008CN101282984A Immunogens for meningitidis-a vaccines
10/08/2008CN101282981A Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
10/08/2008CN101282978A Macrocylic inhibitors of hepatitis c virus
10/08/2008CN101282946A 新的半胱氨酸蛋白酶抑制剂及它们的治疗应用 The new cysteine ​​protease inhibitors and their therapeutic applications
10/08/2008CN101280326A Preparation and application of compound for inhabiting aspergillus fumigatus activity
10/08/2008CN101280314A Gene PA1550 related to twitching motility of pseudomonas aeruginosa
10/08/2008CN101280292A Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
10/08/2008CN101280048A Transparent aquagel having antibacterial action and preparation thereof
10/08/2008CN101280021A Engineered protein against shrimp white spot syndrome virus, preparation and use thereof
10/08/2008CN101279995A Tripterine salt, preparation and use thereof
10/08/2008CN101279993A 3-aryl-8-hydroxychromone-7-O-alpha-D-arabinofuranoside compound, synthetic method and use thereof
10/08/2008CN101279982A Novel method for preparing clavulanate
10/08/2008CN101279980A Separation and purification method of cefminox sodium and preparation of cefminox sodium freeze-dried powder injection
10/08/2008CN101279979A Separation and purification method of cefamandole nafate and preparation of cefathiamidine freeze-dried injectable powder
10/08/2008CN101279978A Separation and purification method of cefathiamidine and preparation of cefathiamidine power injection
10/08/2008CN101279977A Refining method of benemicin raw material and benemicin solution prepared from the benemicin raw material
10/08/2008CN101279970A 2-methyl-5-azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutied derivate, preparation and application thereof
10/08/2008CN101279953A Triazole derivatives used in therapy and medicine salt thereof
10/08/2008CN101279941A Preparation of florfenicol sodium succinate
10/08/2008CN101279061A Functional sterilizing-liquid
10/08/2008CN101279056A Children's antipyretic granule
10/08/2008CN101279048A Chinese medicine for curing cold mainly and preparation thereof
10/08/2008CN101279032A External use medicament for curing itch
10/08/2008CN101279029A Liquid oral vaccine for curing blue-ear pig disease and method of preparing the same
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 1798